Creating the
Biopharma Production
of the Future

Learn how we will transform production of new therapeutics –
to ensure no one is left behind when the next medical breakthroughs arrives

Democratizing Access to New Therapies

Why are Current Limitations in Bioproduction an Issue?

The production of advanced biopharmaceuticals – such as immune and gene therapies – is increasingly hindered by inefficient, inconsistent, and hard-to-scale manufacturing processes.

Despite a growing pipeline of promising, yet also more complex therapeutics, traditional bioreactor operations struggle with low yields, high by-product content, and a lack of real-time process control.

These limitations jeopardize the industry’s ability to deliver breakthrough treatments at scale and at affordable costs.

With AI-Powered Discovery, the New Challenge is now Manufacturability

We Are Transforming Bioproduction -
for the Benefit of Millions of Patients

This is the moment to act.

It is time to close the gap in access and deliver next-generation cures to patients across the world.

Work with us to realize:

  • Faster process development for complex biopharmaceuticals
  • Higher yields and improved product quality
  • Significantly reduced production costs
Back To Top